-Bloomberg
Medtronic Expands Recall of MiniMed 600 Series Insulin Pumps
The FDA has announced that Medtronic Plc (NYSE:MDT) has expanded the Class I recall of its MiniMed 600 series insulin pumps. Medtronic…
Related Posts
Incyte Announces FDA Has Extended New Drug Application Review Period For Ruxolitinib Cream For Treatment Of Atopic Dermatitis To Sept. 21 To Allow Time To Review Additional Analyses Submitted In Response To FDA’s Information Request
Incyte Corporation (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for ruxolitinib cream for the treatment of atopic
Morgan Stanley Maintains Overweight on Microchip Technology, Raises Price Target to $100
Morgan Stanley analyst Joseph Moore maintains Microchip Technology (NASDAQ:MCHP) with a Overweight and raises the price target from $95 to $100.
Chardan Capital Initiates Coverage On Cleanspark with Buy Rating, Announces Price Target of $12
Chardan Capital analyst Brian Dobson initiates coverage on Cleanspark (NASDAQ:CLSK) with a Buy rating and announces Price Target of $12.